Nonalcoholic
fatty liver disease (NAFLD) is a kind of serious fat
disorder that has become a critical problem to human society. Therefore,
finding drugs that are safe and effective has become more and more
important. Erythritol (Ery) is a polyol sweetener with a variety of
biological functions. However, whether Ery has a relieving effect
on NAFLD has not been reported yet. Therefore, we induced HepG2 cells
with oleic acid and palmitic acid as our in vitro model. Moreover,
we choose wild-type mice with tyloxapol and high-fat diet and nuclear
factor E2-related factor 2 (Nrf2) knockout mice with high-fat diet
as our in vivo model. We found that Ery could reverse the lipid accumulation,
oxidative stress, and endoplasmic reticulum stress caused by the NAFLD
model. The mechanism studies showed that Ery promoted the translocation
of Nrf2 from cytoplasm to nucleus, and the molecular simulation docking
results of Ery and Nrf2 showed that there was a hydrogen bond between
them. Moreover, Ery could promote the production of HO-1 and NQO1
antioxidant proteins and inhibit the expression of endoplasmic reticulum
stress proteins GPR78, p-PERK, and CHOP. On the contrast, when Nrf2
was knocked out in mice, Ery lost its protective effect on NAFLD.
In conclusion, we found that the potential mechanism of Ery’s
protective effect is that it plays an antioxidant role by activating
the Nrf2 signaling pathway, thereby inhibiting endoplasmic reticulum
stress and lipid accumulation in NAFLD.